Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Rating Change William Blair analysts initiated coverage on AXS SPAC and New Issue ETF (NASDAQ:SPCX) with a Outperform rating on July 07, 2026. Market Context AXS SPAC and New…
Read moreRating Change Macquarie analysts initiated coverage on AXS SPAC and New Issue ETF (NASDAQ:SPCX) with a Outperform rating on July 07, 2026. Market Context AXS SPAC and New Issue…
Read moreRating Change Cantor Fitzgerald analysts initiated coverage on AXS SPAC and New Issue ETF (NASDAQ:SPCX) with a Overweight rating on July 07, 2026. Market Context AXS SPAC and New…
Read moreRating Change Deutsche Bank analysts initiated coverage on AXS SPAC and New Issue ETF (NASDAQ:SPCX) with a Buy rating on July 07, 2026. Market Context AXS SPAC and New Issue ETF…
Read moreRating Change Chardan Capital analysts reiterated a Buy rating on Metagenomi, Inc. Common Stock (NASDAQ:MGX) on July 07, 2026. Market Context Metagenomi, Inc.
Read moreRating Change Barclays analysts reiterated a Overweight rating on Ategrity Specialty Holdings LLC (NYSE:ASIC) on July 07, 2026. Market Context Ategrity Specialty Holdings LLC…
Read moreRating Change TD Cowen analysts reiterated a Buy rating on Upbound Group, Inc. (NASDAQ:UPBD) on July 07, 2026. Market Context Upbound Group, Inc.
Read moreRating Change Barclays analysts reiterated a Overweight rating on 7.125% Fixed-Rate Reset Subordinated Debentures due 2052 (NYSE:RZC) on July 07, 2026. Market Context 7.125%…
Read moreRating Change Susquehanna analysts reiterated a Neutral rating on JetBlue Airways Corporation (NASDAQ:JBLU) on July 07, 2026. Market Context JetBlue Airways Corporation operates…
Read moreRating Change Truist Securities analysts reiterated a Buy rating on Nuvation Bio Inc. (NYSE:NUVB) on July 07, 2026. Market Context Nuvation Bio Inc.
Read moreRating Change RBC Capital analysts reiterated a Outperform rating on Nuvation Bio Inc. (NYSE:NUVB) on July 07, 2026. Market Context Nuvation Bio Inc.
Read moreRating Change Morgan Stanley analysts initiated coverage on Kingsoft Cloud Holdings Limited (NASDAQ:KC) with a Overweight rating on July 07, 2026. Market Context Kingsoft Cloud…
Read moreRating Change B of A Securities analysts reiterated a Buy rating on Vera Therapeutics, Inc. (NASDAQ:VERA) on July 07, 2026. Market Context Vera Therapeutics, Inc.
Read moreRating Change Truist Securities analysts reiterated a Buy rating on IDEAYA Biosciences, Inc. (NASDAQ:IDYA) on July 07, 2026. Market Context IDEAYA Biosciences, Inc.
Read moreRating Change RBC Capital analysts reiterated a Outperform rating on IDEAYA Biosciences, Inc. (NASDAQ:IDYA) on July 07, 2026. Market Context IDEAYA Biosciences, Inc.
Read moreRating Change HC Wainwright & Co. analysts reiterated a Buy rating on Telix Pharmaceuticals Limited (NASDAQ:TLX) on July 07, 2026. Market Context Telix Pharmaceuticals Limited…
Read moreRating Change Citigroup analysts reiterated a Buy rating on Telix Pharmaceuticals Limited (NASDAQ:TLX) on July 07, 2026. Market Context Telix Pharmaceuticals Limited operates in…
Read moreRating Change Goldman Sachs analysts reiterated a Sell rating on First Hawaiian, Inc. (NASDAQ:FHB) on July 07, 2026. Market Context First Hawaiian, Inc.
Read moreRating Change Barclays analysts reiterated a Equal-Weight rating on First Hawaiian, Inc. (NASDAQ:FHB) on July 07, 2026. Market Context First Hawaiian, Inc.
Read moreRating Change RBC Capital analysts reiterated a Outperform rating on Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) on July 07, 2026. Market Context Mirum Pharmaceuticals, Inc.
Read more
